These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7574889)

  • 1. Clinical application of in vivo tibial K-XRF for monitoring lead stores.
    Wedeen RP; Ty A; Udasin I; Favata EA; Jones KW
    Arch Environ Health; 1995; 50(5):355-61. PubMed ID: 7574889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removing lead from bone: clinical implications of bone lead stores.
    Wedeen RP
    Neurotoxicology; 1992; 13(4):843-52. PubMed ID: 1302310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray fluorescence measurements of lead burden in subjects with low-level community lead exposure.
    Hu H; Milder FL; Burger DE
    Arch Environ Health; 1990; 45(6):335-41. PubMed ID: 2270952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing bone lead content by chelation treatment in chronic lead poisoning: an in vivo X-ray fluorescence and bone biopsy study.
    Batuman V; Wedeen RP; Bogden JD; Balestra DJ; Jones K; Schidlovsky G
    Environ Res; 1989 Feb; 48(1):70-5. PubMed ID: 2492468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of repeated occupational exposure to lead, cessation of exposure, and chelation on levels of lead in bone.
    Hu H; Pepper L; Goldman R
    Am J Ind Med; 1991; 20(6):723-35. PubMed ID: 1805610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead poisoning following ingestion of pieces of lead roofing plates: pica-like behavior in an adult.
    Sabouraud S; Testud F; Descotes J; Benevent M; Soglu G
    Clin Toxicol (Phila); 2008 Mar; 46(3):267-9. PubMed ID: 17906991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of chelation therapy in lead nephropathy.
    Germain MJ; Braden GL; Fitzgibbons JP
    Arch Intern Med; 1984 Dec; 144(12):2419-20. PubMed ID: 6439141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of in vivo X-ray fluorescence determination of skeletal lead stores.
    Sokas RK; Besarab A; McDiarmid MA; Shapiro IM; Bloch P
    Arch Environ Health; 1990; 45(5):268-72. PubMed ID: 2124094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tibial lead determination by 99Tcm radiopharmaceutical x-ray fluorescence.
    Mountford PJ; Green S; Bradley DA; Lewis AD; Morgan WD
    Phys Med Biol; 1994 Apr; 39(4):773-9. PubMed ID: 15552084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated bone lead levels in Queensland, Australia--previously a high lead environment.
    Price J; Grudzinski AW; Craswell PW; Thomas BJ
    Arch Environ Health; 1992; 47(4):256-62. PubMed ID: 1497378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of L-line X-ray fluorescence to estimate bone lead values in lead-poisoned young children and in children, teenagers, and adults from lead-exposed and non-lead-exposed suburban communities in the United States.
    Rosen JF
    Toxicol Ind Health; 1997; 13(2-3):211-8. PubMed ID: 9200789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of lead poisoning due to snooker chalk.
    Dargan PI; Evans PH; House IM; Jones AL
    Arch Dis Child; 2000 Dec; 83(6):519-20. PubMed ID: 11087293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate lead poisoning: trends in blood lead levels in unchelated children.
    Markowitz ME; Bijur PE; Ruff HA; Balbi K; Rosen JF
    Environ Health Perspect; 1996 Sep; 104(9):968-72. PubMed ID: 8899376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential measurements of bone lead content by L X-ray fluorescence in CaNa2EDTA-treated lead-toxic children.
    Rosen JF; Markowitz ME; Bijur PE; Jenks ST; Wielopolski L; Kalef-Ezra JA; Slatkin DN
    Environ Health Perspect; 1991 Feb; 91():57-62. PubMed ID: 1904023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined exchange transfusion and chelation therapy for neonatal lead poisoning.
    Mycyk MB; Leikin JB
    Ann Pharmacother; 2004 May; 38(5):821-4. PubMed ID: 15026564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of K X-ray fluorescence for measuring lead burden in epidemiological studies: high and low lead burdens and measurement uncertainty.
    Hu H; Milder FL; Burger DE
    Environ Health Perspect; 1991 Aug; 94():107-10. PubMed ID: 1954919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of environmental lead exposure in the pediatric population: lessons from Clitty Creek, Thailand.
    Tantanasrikul S; Chaivisuth B; Siriratanapreuk S; Padungtod C; Pleubreukan R; Boonnark T; Worahan S; Bhumiratanarak P; Chomchai C
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S762-8. PubMed ID: 12403258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo x-ray fluorescence measurements of cadmium and lead.
    Nilsson U; Skerfving S
    Scand J Work Environ Health; 1993; 19 Suppl 1():54-8. PubMed ID: 8159974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
    Lin JL; Lin-Tan DT; Hsu KH; Yu CC
    N Engl J Med; 2003 Jan; 348(4):277-86. PubMed ID: 12540640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes.
    Lin JL; Lin-Tan DT; Yu CC; Li YJ; Huang YY; Li KL
    Kidney Int; 2006 Jun; 69(11):2049-56. PubMed ID: 16641918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.